Open Access
CC BY 4.0 · Endosc Int Open 2025; 13: a26415952
DOI: 10.1055/a-2641-5952
Review

Colon capsule endoscopy today: Brief overview of leading UK and Danish initiatives

Jakob Frederik Frokjaer Justsen
1   Kirurgisk Afdeling A, OUH, Odense, Denmark (Ringgold ID: RIN11286)
,
Niels Gellert Olesen
1   Kirurgisk Afdeling A, OUH, Odense, Denmark (Ringgold ID: RIN11286)
,
Gunnar Baatrup
2   Department of Surgery, Odense University Hospital,, Syddansk Universitet Det Sundhedsvidenskabelige Fakultet, Odense, Denmark (Ringgold ID: RIN74340)
,
3   Department of Clinical Research, SDU, Odense, Denmark (Ringgold ID: RIN6174)
4   Afdeling A, OUH, Odense, Denmark (Ringgold ID: RIN11286)
5   Department of Gastroenterology, Pomeranian Medical University in Szczecin, Szczecin, Poland (Ringgold ID: RIN37805)
› Institutsangaben
Preview

Abstract

Background and study aims

In recent years, several large national studies have been published reporting on outcomes of colon capsule endoscopy (CCE) in both symptomatic and screening settings, significantly contributing to the expanding body of real-world evidence on CCE. Therefore, we have compiled these studies to provide an overview of key developments, current challenges, and valuable insights they offer into the evolving role of CCE.

Patients and methods

We examined three multicenter studies reporting on outcomes of CCE including the NHS England study with 4,878 symptomatic patients; the ScotCap pilot with 316 symptomatic patients; the ScotCap registry with 1,087 predominantly symptomatic patients (95.9%); and the CareForColon 2015 study with 1,790 patients in a screening setting. For the ScotCap pilot study, only symptomatic patients were included.

Results

ScotCap pilot reported the highest rate of adequate bowel preparation (79.4%) without using prucalopride. CareForColon2015 achieved a significantly higher rate of complete tests (91.7%) compared with other studies. NHS England reported a notably lower rate of follow-up endoscopy (46.7%), indicating effective patient selection. ScotCap pilot reported one case of missed colorectal cancer. Sensitivity of CCE for detecting polyps ≥ 10 mm ranged from 93.8% to 97.0% on a per-patient basis and from 75.0% to 95.8% on a per-polyp basis in the NHS England and ScotCap trials.

Conclusions

These national CCE programs reveal the complexity of large-scale implementation, driven by variations in definitions and protocols. Harmonized quality metrics and shared definitions of success are essential. Efforts should focus on reducing downstream procedures and fostering cross-system learning.

Supplementary Material



Publikationsverlauf

Eingereicht: 02. Juni 2025

Angenommen: 18. Juni 2025

Accepted Manuscript online:
23. Juni 2025

Artikel online veröffentlicht:
23. Juli 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Jakob Frederik Frokjaer Justsen, Niels Gellert Olesen, Gunnar Baatrup, Anastasios Koulaouzidis. Colon capsule endoscopy today: Brief overview of leading UK and Danish initiatives. Endosc Int Open 2025; 13: a26415952.
DOI: 10.1055/a-2641-5952
 
  • References

  • 1 Turvill J, Haritakis M, Pygall S. et al. Multicentre study of 10,369 symptomatic patients comparing the diagnostic accuracy of colon capsule endoscopy, colonoscopy and CT colonography. Aliment Pharmacol Ther 2025; 61: 1532-1544
  • 2 Baatrup G, Bjørsum-Meyer T, Kaalby L. et al. Choice of colon capsule or colonoscopy versus default colonoscopy in FIT positive patients in the Danish screening programme: a parallel group randomised controlled trial. Gut 2025. Online ahead of print.
  • 3 MacLeod C, Hudson J, Brogan M. et al. ScotCap - A large observational cohort study. Colorectal Dis 2022; 24: 411-421
  • 4 MacLeod C, Rajapaksha N, Brown C. et al. The ScotCap registry: An evaluation of 1000 colon capsule endoscopy procedures carried out in Scotland. Colorectal Dis 2025; 27: e17271
  • 5 Zhao S, Wang S, Pan P. et al. Magnitude, risk factors, and factors associated with adenoma miss rate of tandem colonoscopy: A systematic review and meta-analysis. Gastroenterology 2019; 156: 1661-1674.e11
  • 6 Kaminski MF, Thomas-Gibson S, Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J 2017; 5: 309-334
  • 7 Sepe A, Grossi L, Ciccaglione AF. et al. Tu1148 role of prucalopride (Resolor) in the setting-up of PillCam Colon-Capsule Endoscopy (CCE). Experience from a single centre. Gastroenterology 2014; 146: S766-S766
  • 8 Deding U, Kaalby L, Baatrup G. et al. The Effect of prucalopride on the completion rate and polyp detection rate of colon capsule endoscopies. Clin Epidemiol 2022; 14: 437-444
  • 9 Spada C, Hassan C, Galmiche JP. et al. Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2012; 44: 527-536
  • 10 Deding U, Bjørsum-Meyer T, Kaalby L. et al. Colon capsule endoscopy in colorectal cancer screening: Interim analyses of randomized controlled trial CareForColon2015. Endosc Int Open 2021; 9: E1712-E1719
  • 11 MacLeod C, Oliphant R, Docherty JG. et al. A colorectal cancer missed by colon capsule endoscopy: a case report. BMC Gastroenterol 2022; 22: 258
  • 12 Sulbaran M, Bustamante-Lopez L, Bernardo W. et al. Systematic review and meta-analysis of colon capsule endoscopy accuracy for colorectal cancer screening. An alternative during the Covid-19 pandemic?. J Med Screen 2022; 29: 148-155